Jonaitis, Paulius https://orcid.org/0000-0002-4310-8543
Nyssen, Olga P. https://orcid.org/0000-0002-4920-9310
Saracino, Ilaria Maria
Fiorini, Giulia
Vaira, Dino
Pérez-Aísa, Ángeles
Tepes, Bojan
Castro-Fernandez, Manuel
Pabón-Carrasco, Manuel
Keco-Huerga, Alma
Voynovan, Irina
Lucendo, Alfredo J.
Lanas, Ángel
Martínez-Domínguez, Samuel J.
Almajano, Enrique Alfaro
Rodrigo, Luis
Vologzanina, Ludmila
Brglez Jurecic, Natasa
Denkovski, Maja
Bujanda, Luis
Mahmudov, Umud
Leja, Mārcis
Lerang, Frode
Babayeva, Gülüstan
Bordin, Dmitry S.
Gasbarrini, Antonio
Kupcinskas, Juozas https://orcid.org/0000-0002-8760-7416
Gridnyev, Oleksiy
Rokkas, Theodore
Marcos-Pinto, Ricardo
Phull, Perminder S.
Smith, Sinead M.
Tonkić, Ante
Boltin, Doron
Buzás, György Miklós
Šembera, Štěpán
Şimşek, Halis
Matysiak-Budnik, Tamara
Milivojevic, Vladimir
Marlicz, Wojciech
Venerito, Marino
Boyanova, Lyudmila
Doulberis, Michael
Capelle, Lisette G.
Cano-Català, Anna
Moreira, Leticia
Mégraud, Francis
O’Morain, Colm
Gisbert, Javier P. https://orcid.org/0000-0003-2090-3445
Jonaitis, Laimas https://orcid.org/0000-0001-9086-3675
,
Būmane, Renāte
Mammadov, Emin
Abdulkhakov, Rustam A.
Fadeenko, Galina
Huguet, Jose M.
Article History
Received: 6 March 2023
Accepted: 21 September 2023
First Online: 11 October 2023
Change Date: 1 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-45888-5
Competing interests
: Prof. J. Gisbert has served as speaker, consultant, and advisory member for or has received research funding from Mayoly, Allergan, Diasorin, Gebro Pharma, and Richen. Dr. Nyssen has received research funding from Mayoly and Allergan. The remaining authors have declared no conflict of interest.